Warren Buffett / Berkshire Hathaway Q2 2025 portfolio strikes, in abstract from the newest Berkshire Hathaway 13-F submitting
New and Elevated Positions
-
UnitedHealth Group (UNH) – New 5M-share stake (~US$1.6B worth, 18th largest Berkshire place).
-
First time again in UNH since 2010; inventory jumped 6–7% in after-hours buying and selling on the information.
-
Buy comes regardless of UNH’s troubled 12 months: ~50% share worth drop YTD, DOJ investigation into Medicare billing, CEO resignation, and decreased 2025 earnings outlook.
-
Seen as a contrarian cut price transfer; probably initiated by funding lieutenants Todd Combs or Ted Weschler.
-
-
Nucor (NUE) – New place; steelmaker’s shares jumped practically 8% after disclosure.
-
Lennar (LEN) – Considerably elevated stake; shares rose ~3% after submitting.
-
DR Horton (DHI) – New place in homebuilder; shares up ~3% after submitting.
-
Different smaller stakes – Lamar Promoting (out of doors promoting) and Allegion (safety merchandise).
Trimmed Positions
-
Apple (AAPL) – Additional decreased stake.
-
Financial institution of America (BAC) – Continued promoting.
Context & Hypothesis
-
Berkshire’s Q1 submitting had famous a number of undisclosed holdings underneath SEC confidential therapy; the “thriller inventory” turned out to be a mixture of DR Horton, Nucor, and Lennar stakes.
-
Berkshire’s fairness portfolio worth: ~US$300B.
-
Buffett steps down as Berkshire CEO end-2025; Greg Abel to succeed him and can oversee capital allocation. Buffett stays chairman.
Market Influence
-
UNH, NUE, LEN, and DHI all rallied after the submitting.
-
UNH additionally attracted different notable consumers in Q2, together with Michael Burry and David Tepper.
-
UNH buying and selling at a P/E just below 12, close to decade-long lows.
This text was written by Eamonn Sheridan at investinglive.com.
Source link
